IL6 and cancer: We found that upregulation expression of STAT3 target gene IL6 was influenced by endogenous IFN-λ expression, increasing the activation of the IL-6/JAK/STAT3 pathway which was abnormally hyperactivated in many types of cancer, and this hyperactivation is generally associated with a poor clinical prognosis [19].